ARCHIVES

Chemotherapy After Surgery Extends Survival By 32%

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Centocor Withdraws Yondelis After FDA Calls for New Study

April 29, 2011

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

October 14, 2005

NCI-Approved Clinical Trials

April 26, 2002

In NEJM Letter, Henschke Acknowledges Error In 2006 I-ELCAP Paper; Critics Call For Audit.

August 8, 2008

ACS Asks $1.5 Billion for NCI; Waxman Considers Requiring NIH To Send Budget Directly To Congress

March 4, 1983

NCI Letter To Pittsburgh Details Deficiencies In NSABP Operations

April 8, 1994